# A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor

> **NCT05498519** · PHASE1 · UNKNOWN · sponsor: **Shouyao Holdings (Beijing) Co. LTD** · enrollment: 80 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SY-4798

## Key facts

- **NCT ID:** NCT05498519
- **Lead sponsor:** Shouyao Holdings (Beijing) Co. LTD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498519, "A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05498519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*